These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21709409)

  • 1. Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome.
    Stokowska A; Olsson S; Holmegaard L; Jood K; Blomstrand C; Jern C; Pekna M
    Cerebrovasc Dis; 2011; 32(2):114-22. PubMed ID: 21709409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcome.
    Stokowska A; Olsson S; Holmegaard L; Jood K; Blomstrand C; Jern C; Pekna M
    PLoS One; 2013; 8(8):e72133. PubMed ID: 23977229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
    Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
    Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids in ischemic stroke subtypes.
    Laloux P; Galanti L; Jamart J
    Acta Neurol Belg; 2004 Mar; 104(1):13-9. PubMed ID: 15143957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in plasma complement levels after human ischemic stroke.
    Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
    Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients.
    Michalak S; Kazmierski R; Hellmann A; Wysocka E; Kocialkowska-Adamczewska D; Wencel-Warot A; Nowinski WL
    Cerebrovasc Dis; 2011; 32(2):124-32. PubMed ID: 21778709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population.
    Song IU; Kim JS; Kim YI; Lee KS; Jeong DS; Chung SW
    Cerebrovasc Dis; 2009; 28(6):545-50. PubMed ID: 19844093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Arch Neurol; 2006 Jan; 63(1):60-5. PubMed ID: 16286536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor 15 plasma levels and outcome after ischemic stroke.
    Worthmann H; Kempf T; Widera C; Tryc AB; Goldbecker A; Ma YT; Deb M; Tountopoulou A; Lambrecht J; Heeren M; Lichtinghagen R; Wollert KC; Weissenborn K
    Cerebrovasc Dis; 2011; 32(1):72-8. PubMed ID: 21613788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study.
    Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Thomassen L
    Cerebrovasc Dis; 2009; 28(1):13-7. PubMed ID: 19420917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct.
    Guldiken B; Guldiken S; Turgut B; Turgut N; Demir M; Celik Y; Arikan E; Tugrul A
    Thromb Res; 2007; 120(4):511-6. PubMed ID: 17258300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
    Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits.
    Chang CY; Chen JY; Ke D; Hu ML
    Nutrition; 2005 Oct; 21(10):987-93. PubMed ID: 16157235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6: an early marker for outcome in acute ischemic stroke.
    Waje-Andreassen U; Kråkenes J; Ulvestad E; Thomassen L; Myhr KM; Aarseth J; Vedeler CA
    Acta Neurol Scand; 2005 Jun; 111(6):360-5. PubMed ID: 15876336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
    Tombul T; Atbas C; Anlar O
    J Clin Neurosci; 2005 May; 12(4):429-34. PubMed ID: 15925775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke subtype predicts outcome in young and middle-aged stroke sufferers.
    Redfors P; Jood K; Holmegaard L; Rosengren A; Blomstrand C; Jern C
    Acta Neurol Scand; 2012 Nov; 126(5):329-35. PubMed ID: 22339042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease.
    Perini F; Galloni E; Bolgan I; Bader G; Ruffini R; Arzenton E; Alba S; Azzini C; Bartolomei L; Billo G; Bortolon F; Dudine P; Garofalo PG; L'Erario R; Morra M; Parisen P; Stenta G; Toso V
    Neurol Sci; 2005 Dec; 26(5):310-8. PubMed ID: 16388364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
    Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
    Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.